This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Université De Limoges. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Fabrice Billet: Research on a Curcumin-Based Approach to Peripheral Neuropathies.
Introduction
Fabrice Billet is an inventor associated with Université de Limoges in Limoges, France. His patent work describes a cellulose–cyclodextrin–curcumin complex intended for potential use in treating peripheral neuropathies.
Latest Patents
Billet is associated with 1 patent: “Therapeutic Potential of Cellulose-Cyclodextrin-Curcumin Nanocrystals in the Treatment of Peripheral Neuropathies.” The patent discloses a complex containing cellulose nanocrystals, at least one β-cyclodextrin molecule, and at least one curcumin molecule. It also describes a pharmaceutical composition containing the complex and a pharmaceutically acceptable excipient.
The disclosed approaches include formulations such as hydrogels, subcutaneous implants, implantable pumps, and implanted biofunctionalized nerve conduits. These formats are proposed to support treatment compliance, extended release, and improved pharmacokinetics.
Career Highlights
Billet’s listed patent connects his work with research at Université de Limoges. The invention focuses on a potential therapeutic delivery system for peripheral neuropathies.
Collaborations
The supplied information identifies Martial Caillaud and Franck Sturtz as Billet’s coworkers.
Conclusion
Fabrice Billet’s patent describes a cellulose–cyclodextrin–curcumin complex and possible delivery formats aimed at advancing treatment approaches for peripheral neuropathies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
